Statins Cut All-Cause Mortality 20% in Older Cancer Survivors With Heart Disease
Among 2,714 U.S. cancer survivors aged 65+ drawn from ten NHANES cycles (1999–2018), statin use was independently associated with a 20% reduction in all-cause…
Found 2029 results for "cancer"
Among 2,714 U.S. cancer survivors aged 65+ drawn from ten NHANES cycles (1999–2018), statin use was independently associated with a 20% reduction in all-cause…
Analysis of Global Burden of Disease 2023 data across G20 nations spanning 1990–2023 finds that dietary risks account for 40% of colorectal cancer (CRC)…
In 75,308 apparently healthy adults followed for a median of 21.9 years, four noninvasive autonomic nervous system markers — resting heart rate, heart rate…
Across 21 randomised controlled trials encompassing up to 5,492 cancer patients, structured exercise interventions were associated with a 23% reduction in…
Among 260,659 Korean cancer survivors followed for at least three years, those who maintained or increased physical activity after diagnosis had a 18% lower…
Across 51 prospective cohorts encompassing nearly 9 million adults, higher ultra-processed food (UPF) consumption was associated with elevated hazard ratios…
Four years of daily supplementation with vitamin D3 (2000 IU) and marine omega-3 fatty acids (1 g) produced no statistically significant reduction in four…
Understanding how the immune system fires its first molecular alarm against viral invaders has profound implications for treating both infectious diseases and…
Understanding how mature, fully differentiated cells regulate gene expression in response to hormones has direct implications for kidney disease, cancer, and…
Understanding how cells detect nutrient availability and adjust growth accordingly sits at the heart of aging biology, cancer metabolism, and metabolic…
Most cancer research focuses on familiar signaling pathways—phosphorylation cascades, ubiquitin-mediated degradation, epigenetic silencing—but a largely…
Childhood brain cancer treatment has long been stalled by a brutal paradox: the therapies aggressive enough to shrink tumors inflict lasting cognitive and…
Early cancer detection has long been the most promising — and most elusive — frontier in oncology. The difference between a stage I and stage IV diagnosis can…
Early cancer detection has long been the holy grail of oncology, yet most screening tools target single tumor types, leaving dozens of cancers detectable only…
Inflammatory bowel disease affects roughly 1 million Americans with ulcerative colitis alone, and shifting treatment standards directly determine quality of…
As CAR-T cell therapies move from experimental to standard-of-care for blood cancers, their gastrointestinal side effects have become a pressing clinical…
Small-cell lung cancer has long been one of oncology's most daunting diagnoses — not merely because it spreads aggressively, but because patients who relapse…
Repurposing existing drugs for cancer treatment has emerged as one of oncology's most pragmatic frontiers — bypassing decades of safety testing by leveraging…
Brain cancer research has long focused on tumor cells themselves, but a growing body of evidence implicates the surrounding cellular environment…
For the millions of adults over 50 who undergo major elective surgery each year, the choice of anesthetic technique has long carried clinical debate and real…